Vident Advisory’s DexCom DXCM Stock Holding History

Vident Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$689K	Sell	10,236 -1,568	-13%	-$104K	0.01%	1198
2026 Q1	$741K	Buy	11,804 +4,751	+67%	+$331K	0.01%	1026
2025 Q4	$468K	Sell	7,053 -2,023	-22%	-$131K	﹤0.01%	1203
2025 Q3	$611K	Buy	9,076 +695	+8%	+$55K	0.01%	1087
2025 Q2	$732K	Buy	8,381 +626	+8%	+$49.1K	0.01%	867
2025 Q1	$530K	Buy	7,755 +2,538	+49%	+$207K	0.01%	1004
2024 Q4	$406K	Sell	5,217 -25,324	-83%	-$1.87M	0.01%	1051
2024 Q3	$2.05M	Buy	30,541 +25,040	+455%	+$2.06M	0.05%	380
2024 Q2	$624K	Buy	5,501 +450	+9%	+$56.9K	0.02%	787
2024 Q1	$701K	Buy	5,051 +363	+8%	+$45.6K	0.01%	687
2023 Q4	$582K	Sell	4,688 -156	-3%	-$15.9K	0.01%	720
2023 Q3	$452K	Buy	+4,844	New	+$546K	0.01%	736

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vident Advisory's DXCM Position: Q2 2026 in Review

Vident Advisory reduced its DexCom (DXCM) stake by 13% in Q2 2026, selling an estimated $104K and leaving 10,236 shares worth $689K. The position accounts for 0.01% of the portfolio, ranked #1198.

Vident Advisory first reported a position in DXCM in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.05M in Q3 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Vident Advisory held 10,236 shares of DexCom worth $689K as of Q2 2026.
Vident Advisory sold 1,568 DexCom shares in Q2 2026, an estimated $104K.
DexCom made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1198 holding.
Vident Advisory first reported a position in DexCom in Q3 2023 and has held it in 12 quarters since.
Vident Advisory's DexCom position peaked at $2.05M in Q3 2024.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.